MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) is experiencing significant social media buzz around potential buyout speculation and FDA approval anticipation, despite recent negative clinical trial results and insider selling.

About MoonLake Immunotherapeutics Class A Ordinary Shares

MoonLake Immunotherapeutics is a biotechnology company developing novel immunotherapies.
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) social dominance hit [------] which is 502% higher than it's daily average.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) creators is up 17.83% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up 154.23% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) mentions is up 25.32% from the previous week.
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up 108.33% from the previous week.

Price: $15.80

Price 24-Hour Time-Series Raw Data
Current price action is driven by speculation of a potential buyout or short squeeze and positive anticipation of FDA approval, which are currently outweighing negative clinical trial results and insider selling, despite a recent downgrade from Goldman Sachs.

24-Hour: 0.51% 7-Day: 3.11% 30-Day: -5.91%

1-Year High: $62 on 2025-09-26
1-Year Low: $6.20 on 2025-09-29

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #723 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +491
[--] Months: [---] +304
[--] Year: [---] [----]
1-Year High: [-----] on 2026-02-04
1-Year Low: [--] on 2025-09-29

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +3
[--] Months: [--] [---]
[--] Year: [--] +12
1-Year High: [--] on 2026-01-08
1-Year Low: [--] on 2025-12-30

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [------] +154%
[--] Month: [-------] -64%
[--] Months: [---------] +89%
[--] Year: [---------] +190%
1-Year High: [-------] on 2025-09-29
1-Year Low: [---] on 2025-04-18

Engagements by network (24h): News: [--] TikTok: [--] X: [------] Reddit: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +25%
[--] Month: [---] -32%
[--] Months: [-----] +75%
[--] Year: [-----] +170%
1-Year High: [---] on 2026-01-09
1-Year Low: [--] on 2025-04-18

Mentions by network (24h): News: [--] TikTok: [--] X: [--] Reddit: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last [--] hours which is down 46% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +18%
[--] Month: [---] -26%
[--] Months: [-----] +7.90%
[--] Year: [-----] +199%
1-Year High: [---] on 2026-01-09
1-Year Low: [--] on 2025-04-19

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@RNAiAnalyst	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[---]
@brdq463420	[--]	[--]	[--]	[---]
@Biotekster	[--]	[---]	[--]	[---]
@OptionsAlertsAi	[--]	[---]	[--]	[---]
@Ellie18153	[--]	[--]	[--]	[---]
@Stock_Analysis8	[--]	[--]	[--]	[--]
@David_Tonkinn	[--]	[--]	[--]	[--]
@ayasalmny	[--]	[--]	[--]	[--]

Sentiment: 43%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 43%
Daily Average: 74%
[--] Week: 54% -1%
[--] Month: 39% -29%
[--] Months: 39% -53%
[--] Year: 39% +3%
1-Year High: 100% on 2025-02-24
1-Year Low: 20% on 2025-04-29

Most Supportive Themes:

Positive FDA Approval Anticipation: (30%) Optimism surrounding an upcoming FDA decision is driving positive sentiment and investor interest.
Potential Buyout Speculation: (30%) Market participants are discussing the possibility of a company acquisition, which could lead to a significant price increase.
Short Squeeze Opportunity: (25%) Social media buzz suggests a potential short squeeze, attracting traders looking for rapid gains.

Most Critical Themes:

Negative Clinical Trial Results: (15%) Recent trial data has been unfavorable, raising concerns about the company's drug development pipeline.
Insider Selling: (10%) A significant insider sale has been noted, which can be interpreted as a negative signal by the market.

Social Dominance: 0.00572%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00572%
Daily Average: 0.012%
[--] Week: 0.00574% +0.0004400000000000003%
[--] Month: 0.012% -0.033%
[--] Months: 0.012% +0.0029%
[--] Year: 0.012% +0.0075%
1-Year High: 0.10% on 2026-01-09
1-Year Low: 0.0025% on 2025-04-18

Market Dominance: 0.00127%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00127%
Daily Average: 0%
1-Year High: 0.089% on 2025-03-27
1-Year Low: 0.00049% on 2025-09-29

Market Cap: $1,117,263,514

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,117,263,514
Daily Average: $2,129,384,958
[--] Week: $1,110,887,248 -0.44%
[--] Month: $1,117,263,514 -5.90%
[--] Months: $1,117,263,514 -68%
[--] Year: $1,117,263,514 -59%
1-Year High: $3,936,451,910 on 2025-09-26
1-Year Low: $396,566,255 on 2025-09-29

Top MoonLake Immunotherapeutics Class A Ordinary Shares Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"@Biohazard3737 There hasnt been a move to single pivotal trials yet not formalized and not put into practice either. $mltx alignmemt is explicitly based on [--] trials (one a phase 2). The single pivotal trial talk was just more hot FDA air"
X Link @RNAiAnalyst 2026-02-16T10:01Z 21.2K followers, [---] engagements

"🎯 : $OCG $NIVVD $GEOS $MLTX $ORGO $VUZI $LINK $NMTC #__ #StockMarket #_ http://t.me/Tawsiiatfalcon1 http://t.me/Tawsiiatfalcon1"
X Link @walid2021r 2026-02-15T20:46Z [---] followers, [---] engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, 11.2K engagements

"⚠ . ( ) : $OCG $NIVVD $GEOS $MLTX $ORGO $VUZI $LINK $NMTC #_ #_ http://t.me/Tawsiiatfalcon1 http://t.me/Tawsiiatfalcon1"
X Link @raheelmohmmed1 2026-02-15T19:18Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing